Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004678318 | SCV005179945 | uncertain significance | Inborn genetic diseases | 2024-04-12 | criteria provided, single submitter | clinical testing | The c.517G>A (p.D173N) alteration is located in exon 6 (coding exon 5) of the WDR72 gene. This alteration results from a G to A substitution at nucleotide position 517, causing the aspartic acid (D) at amino acid position 173 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005003783 | SCV005631152 | uncertain significance | Amelogenesis imperfecta hypomaturation type 2A3 | 2024-04-30 | criteria provided, single submitter | clinical testing |